tetradecanoylphorbol acetate has been researched along with cicaprost in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diglio, CA; Grossi, IM; Honn, KV; Tang, DG; Tang, KQ | 1 |
| Khanin, M; Liel, Y; Rimon, G | 1 |
| Bond, R; Cook, J; Gilkeson, G; Guyton, K; Halushka, P; Reilly, C | 1 |
| Bretschneider, E; Censarek, P; Fischer, JW; Meyer-Kirchrath, J; Pape, R; Rabausch, K; Sarbia, M; Schrör, K; Weber, AA | 1 |
| Lai, HK; Lau, AH; Leung, SL; Tsang, SY; Wise, H; Wong, YH; Yeung, BH | 1 |
5 other study(ies) available for tetradecanoylphorbol acetate and cicaprost
| Article | Year |
|---|---|
Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adenylyl Cyclases; Animals; Antineoplastic Agents; Cell Adhesion; Cyclic AMP; Epoprostenol; Hydroxyeicosatetraenoic Acids; Iloprost; In Vitro Techniques; Integrins; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1995 |
Differential effect of TPA on PGE2 and cicaprost-induced cAMP synthesis in UMR-106 cells.
Topics: Animals; Cell Line; Colforsin; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Sodium Fluoride; Tetradecanoylphorbol Acetate; Time Factors | 1999 |
Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Topics: Animals; Cyclopentanes; DNA-Binding Proteins; Enzyme Activation; Epoprostenol; I-kappa B Proteins; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-KappaB Inhibitor alpha; Nitric Oxide; Phosphorylation; Prostaglandin D2; Protein Processing, Post-Translational; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidinediones; Thromboxane B2; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins.
Topics: Alprostadil; Blood Coagulation; Bucladesine; Carotid Artery Diseases; Carotid Artery, Internal; Cells, Cultured; Colforsin; Coronary Vessels; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Epoprostenol; Etoricoxib; Gene Expression Profiling; Gene Expression Regulation; Humans; Iloprost; Isoquinolines; Mammary Arteries; Membrane Proteins; Models, Biological; Myocytes, Smooth Muscle; Oligonucleotide Array Sequence Analysis; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyridines; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; RNA, Messenger; Saphenous Vein; Second Messenger Systems; Sulfonamides; Sulfones; Tetradecanoylphorbol Acetate; Thrombomodulin; Thrombophilia; Vasodilator Agents | 2005 |
Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Survival; Epoprostenol; Humans; Integrin beta3; Leukemia, Erythroblastic, Acute; Platelet Membrane Glycoprotein IIb; Receptors, Epoprostenol; Signal Transduction; STAT3 Transcription Factor; Tetradecanoylphorbol Acetate | 2012 |